In diseases with complex etiologies and heterogeneity, such as HCC, these gene signatures, which were composed of multiple genes, demonstrated greater reliability compared to biomarkers such as AFP, PD-L1, and TMB (53). The gene discussed is CD274; the disease is hepatocellular carcinoma.